Urotensin Ⅱ and Mitogen-activated Protein Kinase Expression of Batroxobin and Ischemic Preconditioning on Ischemic Rats Cerebral Injury

XU Jia-liang,JIANG Mei-zi,HE Zhi-yi,LI Lei

DOI: https://doi.org/10.3969/j.issn.1006-2963.2009.01.007

2009-01-01

Abstract:Objective To investigate the pathophysiologic effects of Urotensin Ⅱ(UⅡ) and mitogen-activated protein kinase(MAPK) signal conducting pathway on ischemic cerebral injury,and batroxobin improving ischemic tolerance and cerebral protection.Methods We made ischemic preconditioning focal ischemia model,and adopted immunohistochemical method to determine each subgroup UⅡ and orphan G-protein-coupled receptor(GPR14) activities,and western blot method to determine subgroup ERK and JNK activities expression.We divided the rats into four groups: sham group,ischemic injury group,ischemic preconditioning group,ischemic preconditioning+batroxobin group and each group was divided into four subgroups at permanent middle cerebral artery occlusion(MCAO) 3 h,6 h,24 h,72 h.Results At permanent MCAO 24 h,each group UⅡ,GPR14 positive cells expression reached peak;at the same time point batroxobin+ischemic preconditioning could improve notably the neurologic deficient symptoms in rats;at every observed time end-point,batroxobin+ischemic preconditioning could attenuate obviously the UⅡ,GPR14 exression,enhance the phosphorylation of ERK expression,and down regulate the phosphorylation of JNK expression.Conclusions Batroxobin could inhibit UⅡ synthesis as to decrease the vaso-constriction effect,improve ERK survival way,and inhibit JNK death way to enhance the cerebral ischemic tolerance and cerebral protection.